Literature DB >> 1283340

Modified tetrachrome method for osteoid and defectively mineralized bone in paraffin sections.

Z A Ralis1, G Watkins.   

Abstract

A new modification of the tetrachrome method for bone osteoid in paraffin sections has been designed. The modified tetrachrome method suitable for routine use in any histology laboratory retains the simplicity of the original method and gives good results on the freshly fixed, decalcified, paraffin embedded material. Osteoid tissue is stained deep blue and normally mineralized bone is stained red. Defectively mineralized bone stains pale blue or pink and the cellular population is clearly identifiable. The ability to distinguish the osteoid tissue from mineralized bone and connective tissue and cartilage makes diagnosis of osteomalacia or osteoid producing tumors or assessment of ossification process straightforward, without the need for undecalcified sections. By displaying simultaneously irregularities in the mineralized matrix and morphology of bone cells, the method also permits the diagnosis of conditions recently described in patients with osteoporotic fractures, such as osteocytic degeneration and bone tissue defects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1283340     DOI: 10.3109/10520299209110046

Source DB:  PubMed          Journal:  Biotech Histochem        ISSN: 1052-0295            Impact factor:   1.718


  15 in total

1.  Generation of functional mesenchymal stem cells from different induced pluripotent stem cell lines.

Authors:  Kim Hynes; Danijela Menicanin; Krzysztof Mrozik; Stan Gronthos; P Mark Bartold
Journal:  Stem Cells Dev       Date:  2014-02-07       Impact factor: 3.272

2.  CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines.

Authors:  Daniela Sicoli; Xuanmao Jiao; Xiaoming Ju; Marco Velasco-Velazquez; Adam Ertel; Sankar Addya; Zhiping Li; Sebastiano Andò; Alessandro Fatatis; Bishnuhari Paudyal; Massimo Cristofanilli; Mathew L Thakur; Michael P Lisanti; Richard G Pestell
Journal:  Cancer Res       Date:  2014-12-01       Impact factor: 12.701

3.  Ovine model for critical-size tibial segmental defects.

Authors:  Chris Christou; Rema A Oliver; Matthew H Pelletier; William R Walsh
Journal:  Comp Med       Date:  2014-10       Impact factor: 0.982

4.  Periodontal-ligament-derived stem cells exhibit the capacity for long-term survival, self-renewal, and regeneration of multiple tissue types in vivo.

Authors:  Danijela Menicanin; Krzysztof Marek Mrozik; Naohisa Wada; Victor Marino; Songtao Shi; P Mark Bartold; Stan Gronthos
Journal:  Stem Cells Dev       Date:  2014-02-06       Impact factor: 3.272

5.  Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2).

Authors:  Diah S Bramono; Sadasivam Murali; Bina Rai; Ling Ling; Wei Theng Poh; Zophia Xuehui Lim; Gary S Stein; Victor Nurcombe; Andre J van Wijnen; Simon M Cool
Journal:  Bone       Date:  2011-12-28       Impact factor: 4.398

6.  Novel polychrome staining distinguishing osteochondral tissue and bone cells in decalcified paraffin sections.

Authors:  Teppei Nakamura; Kanako Sumi; Erika Tsuji; Marina Hosotani; Takashi Namba; Osamu Ichii; Takao Irie; Ken-Ichi Nagasaki; Yasuhiro Kon; Takashi Mishima; Tomoji Yoshiyasu
Journal:  Cell Tissue Res       Date:  2021-08-19       Impact factor: 5.249

7.  Bone-targeting parathyroid hormone conjugates outperform unmodified PTH in the anabolic treatment of osteoporosis in rats.

Authors:  Yang Yang; Ali Aghazadeh-Habashi; Arash Panahifar; Yuchin Wu; Krishna H Bhandari; Michael R Doschak
Journal:  Drug Deliv Transl Res       Date:  2017-08       Impact factor: 4.617

8.  Zoledronic acid preserves bone structure and increases survival but does not limit tumour incidence in a prostate cancer bone metastasis model.

Authors:  Tzong-Tyng Hung; Jeffrey Chan; Pamela J Russell; Carl A Power
Journal:  PLoS One       Date:  2011-05-16       Impact factor: 3.240

9.  Establishing criteria for human mesenchymal stem cell potency.

Authors:  Rebekah M Samsonraj; Bina Rai; Padmapriya Sathiyanathan; Kia Joo Puan; Olaf Rötzschke; James H Hui; Michael Raghunath; Lawrence W Stanton; Victor Nurcombe; Simon M Cool
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

10.  Autologous bone marrow clot as an alternative to autograft for bone defect healing.

Authors:  Z X H Lim; B Rai; T C Tan; A K Ramruttun; J H Hui; V Nurcombe; S H Teoh; S M Cool
Journal:  Bone Joint Res       Date:  2019-04-02       Impact factor: 5.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.